短QT综合征患者皮下植入式心律转复除颤器的应用
Use of a subcutaneous ICD in a patient with short QT syndrome.
作者信息
Mondoly Pierre, Cardin Christelle, Rollin Anne, Duparc Alexandre, Maury Philippe
机构信息
Cardiology University Hospital Rangueil 31059 Toulouse Cedex 09 France.
出版信息
Clin Case Rep. 2015 Nov 11;4(1):35-8. doi: 10.1002/ccr3.432. eCollection 2016 Jan.
Abstract
Short QT syndrome carries the risk for inappropriate therapies using transvenous ICD because of overdetection of the ample T wave. SQT syndrome may also benefit from subcutaneous ICD, although additional cases are needed to affirm the safety of such device in this setting.
摘要
短QT综合征因T波高大易被过度检测，存在使用经静脉植入式心律转复除颤器（ICD）进行不恰当治疗的风险。短QT综合征也可能从皮下ICD中获益，尽管还需要更多病例来证实该装置在此情况下的安全性。
相似文献
1
Use of a subcutaneous ICD in a patient with short QT syndrome.
Clin Case Rep. 2015 Nov 11;4(1):35-8. doi: 10.1002/ccr3.432. eCollection 2016 Jan.
2
Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A.
J Cardiol Cases. 2020 Aug 11;22(5):238-241. doi: 10.1016/j.jccase.2020.07.007. eCollection 2020 Nov.
3
Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
J Cardiovasc Electrophysiol. 2003 Dec;14(12):1273-7. doi: 10.1046/j.1540-8167.2003.03278.x.
4
Inappropriate ICD discharge due to T-wave oversensing in a patient with short QT syndrome.
Pacing Clin Electrophysiol. 2010 Jan;33(1):113-6. doi: 10.1111/j.1540-8159.2009.02538.x. Epub 2009 Sep 30.
5
Change of sensing vector in the subcutaneous ICD during follow-up and after device replacement.
J Cardiovasc Electrophysiol. 2018 Sep;29(9):1241-1247. doi: 10.1111/jce.13647. Epub 2018 Jun 19.
6
Replacement of an Implantable Cardioverter-Defibrillator (ICD) with a New Standard Subcutaneous ICD System in a Patient with Jervell and Lange-Nielsen Syndrome.
Int Heart J. 2019 Sep 27;60(5):1206-1210. doi: 10.1536/ihj.19-076. Epub 2019 Sep 4.
7
Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
Kardiol Pol. 2018;76(12):1687-1696. doi: 10.5603/KP.a2018.0177. Epub 2018 Sep 25.
8
Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.
Heart Rhythm. 2013 Jan;10(1):29-36. doi: 10.1016/j.hrthm.2012.09.126. Epub 2012 Sep 29.
9
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
10
Inappropriate pacing inhibition triggered by QT prolongation due to T wave oversensing in an ICD recipient presenting with long QT syndrome.
Intern Med. 2011;50(9):1021-4. doi: 10.2169/internalmedicine.50.4837. Epub 2011 May 1.
引用本文的文献
1
The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.
Arq Bras Cardiol. 2019 Mar;112(3):326-368. doi: 10.5935/abc.20190048.
2
Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome.
Clin Res Cardiol. 2019 Oct;108(10):1140-1146. doi: 10.1007/s00392-019-01449-3. Epub 2019 Mar 16.
3
Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.
Acta Pharmacol Sin. 2018 Mar;39(3):382-392. doi: 10.1038/aps.2017.86. Epub 2017 Oct 26.
4
In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
PLoS One. 2017 Jun 20;12(6):e0179515. doi: 10.1371/journal.pone.0179515. eCollection 2017.
5
Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
Biomed Eng Online. 2017 Jun 7;16(1):69. doi: 10.1186/s12938-017-0369-0.
本文引用的文献
1
HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.
Heart Rhythm. 2013 Dec;10(12):1932-63. doi: 10.1016/j.hrthm.2013.05.014. Epub 2013 Aug 30.
2
The short QT syndrome: proposed diagnostic criteria.
J Am Coll Cardiol. 2011 Feb 15;57(7):802-12. doi: 10.1016/j.jacc.2010.09.048.
3
Clinical characteristics and treatment of short QT syndrome.
Expert Rev Cardiovasc Ther. 2005 Jul;3(4):611-7. doi: 10.1586/14779072.3.4.611.
4
Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
J Cardiovasc Electrophysiol. 2003 Dec;14(12):1273-7. doi: 10.1046/j.1540-8167.2003.03278.x.
Zotero 插件